Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Genesis Healthcare (GEN) Competitors

Genesis Healthcare logo

GEN vs. ADSK, NTES, TEAM, MSTR, SQ, DDOG, SNOW, EA, VEEV, and NET

Should you be buying Genesis Healthcare stock or one of its competitors? The main competitors of Genesis Healthcare include Autodesk (ADSK), NetEase (NTES), Atlassian (TEAM), MicroStrategy (MSTR), Block (SQ), Datadog (DDOG), Snowflake (SNOW), Electronic Arts (EA), Veeva Systems (VEEV), and Cloudflare (NET). These companies are all part of the "prepackaged software" industry.

Genesis Healthcare vs.

Autodesk (NASDAQ:ADSK) and Genesis Healthcare (NYSE:GEN) are both large-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings, media sentiment and community ranking.

Autodesk has a net margin of 18.21% compared to Genesis Healthcare's net margin of 17.83%. Genesis Healthcare's return on equity of 155.48% beat Autodesk's return on equity.

Company Net Margins Return on Equity Return on Assets
Autodesk18.21% 59.41% 12.17%
Genesis Healthcare 17.83%155.48%9.12%

Autodesk has a beta of 1.48, suggesting that its share price is 48% more volatile than the S&P 500. Comparatively, Genesis Healthcare has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500.

90.2% of Autodesk shares are held by institutional investors. Comparatively, 82.1% of Genesis Healthcare shares are held by institutional investors. 0.1% of Autodesk shares are held by insiders. Comparatively, 3.3% of Genesis Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Autodesk presently has a consensus price target of $292.95, suggesting a potential upside of 3.22%. Genesis Healthcare has a consensus price target of $29.33, suggesting a potential upside of 0.77%. Given Autodesk's stronger consensus rating and higher probable upside, equities analysts clearly believe Autodesk is more favorable than Genesis Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Autodesk
0 Sell rating(s)
8 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.65
Genesis Healthcare
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Autodesk has higher revenue and earnings than Genesis Healthcare. Genesis Healthcare is trading at a lower price-to-earnings ratio than Autodesk, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Autodesk$5.81B10.54$906M$4.6261.43
Genesis Healthcare$2.80B6.65$836M$0.9032.34

Autodesk received 763 more outperform votes than Genesis Healthcare when rated by MarketBeat users. Likewise, 69.18% of users gave Autodesk an outperform vote while only 65.56% of users gave Genesis Healthcare an outperform vote.

CompanyUnderperformOutperform
AutodeskOutperform Votes
1237
69.18%
Underperform Votes
551
30.82%
Genesis HealthcareOutperform Votes
474
65.56%
Underperform Votes
249
34.44%

In the previous week, Autodesk had 1 more articles in the media than Genesis Healthcare. MarketBeat recorded 12 mentions for Autodesk and 11 mentions for Genesis Healthcare. Autodesk's average media sentiment score of 0.87 beat Genesis Healthcare's score of 0.00 indicating that Autodesk is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Autodesk
7 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Genesis Healthcare
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Autodesk beats Genesis Healthcare on 17 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GEN vs. The Competition

MetricGenesis HealthcarePrepackaged software IndustryBusiness SectorNYSE Exchange
Market Cap$18.61B$23.32B$6.83B$19.18B
Dividend Yield3.05%2.21%3.23%3.52%
P/E Ratio32.3471.3644.7931.76
Price / Sales6.6544.39218.0817.87
Price / Cash8.4281.2225.2620.46
Price / Book-181.9410.294.725.38
Net Income$836M$453.53M$119.95M$984.37M

Genesis Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GEN
Genesis Healthcare
1.2744 of 5 stars
$29.11
+8.2%
$29.33
+0.8%
+61.6%$18.61B$2.80B32.342,700Dividend Announcement
Analyst Forecast
Gap Up
High Trading Volume
ADSK
Autodesk
4.1941 of 5 stars
$289.39
+1.0%
$292.95
+1.2%
+46.0%$62.37B$5.81B59.1814,100
NTES
NetEase
4.7182 of 5 stars
$82.16
+1.3%
$112.67
+37.1%
-25.2%$52.76B$14.57B13.4029,128Short Interest ↑
TEAM
Atlassian
4.6417 of 5 stars
$191.72
+1.6%
$212.47
+10.8%
+7.0%$49.90B$4.36B-165.2812,157Insider Selling
MSTR
MicroStrategy
3.9224 of 5 stars
$257.21
+0.7%
$220.00
-14.5%
+488.5%$45.62B$496.26M-184.251,934Earnings Report
Analyst Forecast
SQ
Block
4.7053 of 5 stars
$73.56
-1.2%
$88.79
+20.7%
+86.9%$45.39B$23.50B57.4712,985Upcoming Earnings
Short Interest ↓
DDOG
Datadog
4.6519 of 5 stars
$129.01
+2.1%
$142.54
+10.5%
+59.4%$43.50B$2.39B286.705,200Upcoming Earnings
Short Interest ↑
SNOW
Snowflake
4.6214 of 5 stars
$118.43
+0.9%
$174.74
+47.5%
-17.4%$39.70B$3.21B-38.707,004
EA
Electronic Arts
4.3139 of 5 stars
$145.75
+1.1%
$162.76
+11.7%
+22.9%$38.73B$7.30B34.2913,700Dividend Announcement
Analyst Forecast
Insider Selling
Short Interest ↑
Analyst Revision
News Coverage
VEEV
Veeva Systems
4.7068 of 5 stars
$213.91
+0.8%
$232.87
+8.9%
+12.8%$34.64B$2.36B57.047,172Analyst Forecast
NET
Cloudflare
3.8242 of 5 stars
$88.52
+0.7%
$91.72
+3.6%
+60.7%$30.25B$1.48B-305.243,682Upcoming Earnings

Related Companies and Tools


This page (NYSE:GEN) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners